Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

A panelist discusses how first-line (1L) therapies, including EGFR tyrosine kinase inhibitors (TKIs) such as osimertinib, are the standard of care for treating locally advanced or metastatic ...

fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur. ... Tumor DNA in the Blood Can ...

The most common form of lung cancer affects the airways leading into the lungs, causing symptoms such as shortness of breath, wheezing, and a persistent cough that may produce blood or phlegm.

If you or a loved one has recently received a diagnosis of non-small cell lung cancer, here are 10 terms you’ll want to know. Non-small cell lung cancer (NSCLC) and the many terms related to it ...